13D/G large-stake feed

Latest 13D/G Reports

Since 06 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

CROSSLINK CAPITAL INC stake in CHIME FINANCIAL, INC.

Holder CIK 0001104329

13G/A CHYM
CIK
0001104329
Issuer
Chime Financial, Inc.
Security
CHYM
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
7.5% / 26,306,064 shares
Filed
15 May 2026, 16:11:51 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ICQ BB GP, LLC stake in BLUE OWL CAPITAL INC.

Holder CIK 0001832801

13G/A OWL
CIK
0001832801
Issuer
BLUE OWL CAPITAL INC.
Security
OWL
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.1% / 34,353,844 shares
Filed
15 May 2026, 16:11:49 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

HARRIS ASSOCIATES L P stake in ICON plc

Holder CIK 0000813917

13G ICLR
CIK
0000813917
Issuer
ICON PLC
Security
ICLR
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
5.7% / 4,351,317 shares
Filed
15 May 2026, 16:11:48 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Commodore Capital LP stake in LB PHARMACEUTICALS INC

Holder CIK 0001831942

13G/A LBRX
CIK
0001831942
Issuer
LB PHARMACEUTICALS INC
Security
LBRX
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
6.8% / 1,972,369 shares
Filed
15 May 2026, 16:11:43 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

EdgePoint Investment Group Inc. stake in OR ROYALTIES INC.

Holder CIK 0001481669

13G/A OR
CIK
0001481669
Issuer
OR Royalties Inc.
Security
OR
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
10% / 19,460,644 shares
Filed
15 May 2026, 16:11:26 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

BIOTECHNOLOGY VALUE FUND L P stake in ImageneBio, Inc.

Holder CIK 0000918923

13G/A IMA
CIK
0000918923
Issuer
ImageneBio, Inc.
Security
IMA
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
9.9% / 1,110,002 shares
Filed
15 May 2026, 16:11:25 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1,201-1,250 of 4,055
Per page
50
Current page
25

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

10%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

CROSSLINK CAPITAL INC

CHIME FINANCIAL, INC. (CHYM)

Schedule 13G/A Ownership 7.5% Filing-backed
CIK
000110432926000007
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
7.5%
Filed
15 May 2026, 16:11:51 UTC
Period
31 Mar 2026

CROSSLINK CAPITAL INC filed Schedule 13G/A for CHIME FINANCIAL, INC. (CHYM). Reported class ownership: 7.5%. Ownership change: -1.1%. Share change: -10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ICQ BB GP, LLC

BLUE OWL CAPITAL INC. (OWL)

Schedule 13G/A Ownership 5.1% Filing-backed
CIK
000101143826000345
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
5.1%
Filed
15 May 2026, 16:11:49 UTC
Period
31 Mar 2026

ICQ BB GP, LLC filed Schedule 13G/A for BLUE OWL CAPITAL INC. (OWL). Reported class ownership: 5.1%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

HARRIS ASSOCIATES L P

ICON plc (ICLR)

Schedule 13G Ownership 5.7% Filing-backed
CIK
000081391726000033
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
5.7%
Filed
15 May 2026, 16:11:48 UTC
Period
31 Mar 2026

HARRIS ASSOCIATES L P filed Schedule 13G for ICON plc (ICLR). Reported class ownership: 5.7%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Commodore Capital LP

LB PHARMACEUTICALS INC (LBRX)

Schedule 13G/A Ownership 6.8% Filing-backed
CIK
000183194226000020
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
6.8%
Filed
15 May 2026, 16:11:43 UTC
Period
31 Mar 2026

Commodore Capital LP filed Schedule 13G/A for LB PHARMACEUTICALS INC (LBRX). Reported class ownership: 6.8%. Ownership change: +1.3%. Share change: +61%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

EdgePoint Investment Group Inc.

OR ROYALTIES INC. (OR)

Schedule 13G/A Ownership 10% Filing-backed
CIK
000117266126002308
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
10%
Filed
15 May 2026, 16:11:26 UTC
Period
31 Mar 2026

EdgePoint Investment Group Inc. filed Schedule 13G/A for OR ROYALTIES INC. (OR). Reported class ownership: 10%. Ownership change: -1.6%. Share change: -13%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

BIOTECHNOLOGY VALUE FUND L P

ImageneBio, Inc. (IMA)

Schedule 13G/A Ownership 9.9% Filing-backed
CIK
000092189526001396
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
9.9%
Filed
15 May 2026, 16:11:25 UTC
Period
31 Mar 2026

BIOTECHNOLOGY VALUE FUND L P filed Schedule 13G/A for ImageneBio, Inc. (IMA). Reported class ownership: 9.9%. Ownership change: +2.7%. Share change: +38%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
CROSSLINK CAPITAL INC CIK 0001104329 CHYM CHIME FINANCIAL, INC. 26,306,064 7.5% SEC filing
ICQ BB GP, LLC CIK 0001832801 OWL BLUE OWL CAPITAL INC. 34,353,844 5.1% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 ICLR ICON plc 4,351,317 5.7% SEC filing
Commodore Capital LP CIK 0001831942 LBRX LB PHARMACEUTICALS INC 1,972,369 6.8% SEC filing
EdgePoint Investment Group Inc. CIK 0001481669 OR OR ROYALTIES INC. 19,460,644 10% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 IMA ImageneBio, Inc. 1,110,002 9.9% SEC filing
Rosenstein Justin CIK 0001823099 ASAN Asana, Inc. 6,322,002 3.8% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 ANRO Alto Neuroscience, Inc. 1,170,865 3.7% SEC filing
Commodore Capital LP CIK 0001831942 IKT Inhibikase Therapeutics, Inc. 14,054,940 9.9% SEC filing
Durable Capital Partners LP CIK 0001798849 FOUR Shift4 Payments, Inc. 6,165,793 7.6% SEC filing
Durable Capital Partners LP CIK 0001798849 RBC RBC Bearings Incorporated 2,275,636 7.2% SEC filing
EdgePoint Investment Group Inc. CIK 0001481669 MAT MATTEL, INC. 49,140,882 16% SEC filing
Portolan Capital Management, LLC CIK 0001350290 CSTL Castle Biosciences, Inc. 1,350,283 4.4% SEC filing
PROPPER KERRY CIK 0001282327 FVN Future Vision II Acquisition Corp. 195,000 2.6% SEC filing
BRC Group Holdings, Inc. CIK 0001464790 DDI DoubleDown Interactive Co., Ltd. 181,846 7.3% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 GLUE Monte Rosa Therapeutics, Inc. 5,085,886 6.3% SEC filing
Kaufman Kapital LLC CIK 0002033227 BOF BranchOut Food Inc. 1,689,676 11% SEC filing
S.H.N. Financial Investments Ltd. CIK 0001890802 ASNS Actelis Networks Inc 812,500 3% SEC filing
DISCIPLINED GROWTH INVESTORS INC /MN CIK 0001050442 CLB Core Laboratories Inc. /DE/ 4,937,115 11% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 SM SM Energy Co 14,493,791 6.1% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 NTSK Netskope Inc 8,960,263 3.7% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 COLD Americold Realty Trust, Inc. 14,726,365 5.2% SEC filing
CF Series DAT A LP CIK 0002084744 ORBS Eightco Holdings Inc. 22,958,143 6.1% SEC filing
MPM BioImpact LLC CIK 0001687078 DBVT DBV TECHNOLOGIES S.A. 26,066,806 8.8% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 FHTX Foghorn Therapeutics Inc. 5,866,613 10% SEC filing
Greenhouse Funds LLLP CIK 0001626220 VYX NCR Voyix Corporation 22,431,714 16% SEC filing
Rubric Capital Management LP CIK 0001687509 ZYME Zymeworks Inc. 7,000,000 9.5% SEC filing
Portolan Capital Management, LLC CIK 0001350290 VPG Vishay Precision Group, Inc. 1,019,868 8.3% SEC filing
MPM BioImpact LLC CIK 0001687078 FBRX Forte Biosciences, Inc. 1,000,682 7.2% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 CRBG Corebridge Financial, Inc. 24,964,260 5.2% SEC filing
Gates Capital Management, Inc. CIK 0001312908 TIC TIC Solutions, Inc. 21,850,000 9.9% SEC filing
Rubric Capital Management LP CIK 0001687509 SPRY ARS Pharmaceuticals, Inc. 8,000,000 8.1% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 FDMT 4D Molecular Therapeutics, Inc. 5,346,519 10% SEC filing
Dimension Capital II, L.P. CIK 0002040933 ODTX Odyssey Therapeutics, Inc. 3,333,516 7.1% SEC filing
PROPPER KERRY CIK 0001282327 CAPN Cayson Acquisition Corp. 0 0% SEC filing
Rubric Capital Management LP CIK 0001687509 SDGR Schrodinger, Inc. 6,000,000 9.3% SEC filing
Rubric Capital Management LP CIK 0001687509 PRTA PROTHENA CORPORATION PUBLIC LIMITED COMPANY 5,000,000 9.3% SEC filing
Portolan Capital Management, LLC CIK 0001350290 REAX Real Brokerage Inc 14,519,848 6.8% SEC filing
Andreessen Horowitz Fund IV, L.P. CIK 0001603198 OMDA Omada Health, Inc. 2,461,709 4.2% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 ELDN Eledon Pharmaceuticals, Inc. 7,868,419 10% SEC filing
Rubric Capital Management LP CIK 0001687509 NFE New Fortress Energy Inc. 0 0% SEC filing
Commodore Capital LP CIK 0001831942 ANRO Alto Neuroscience, Inc. 3,588,180 9.9% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 CMPX Compass Therapeutics, Inc. 7,764,842 4.3% SEC filing
Jericho Capital Asset Management L.P. CIK 0001525234 LION Lionsgate Studios Corp. 18,815,105 6.5% SEC filing
Portolan Capital Management, LLC CIK 0001350290 QTRX Quanterix Corp 2,945,823 6.2% SEC filing
5AM Partners VII, LLC CIK 0001873545 SRZN Surrozen, Inc. 1,162,500 9.5% SEC filing
HBM Healthcare Investments (Cayman) Ltd. CIK 0001232258 ALXO ALX ONCOLOGY HOLDINGS INC 8,590,692 6.5% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 CGEM Cullinan Therapeutics, Inc. 6,161,469 10% SEC filing
Soroban Capital Partners LP CIK 0001517857 DPZ Domino's Pizza Inc. 2,495,194 7.4% SEC filing
Greenhouse Funds LLLP CIK 0001626220 NEO NEOGENOMICS, INC. 9,215,903 7.1% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .